Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Investigation of the clinical condition and safety in patients with cervical dystonia
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| E2014 |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Overall assessments of the improvement in the seriousness of seizures | Improvement is based on the 5 following elements: 1) Eminent improvement 2) Improvement 3) Improvement a little invariability 5) Exacerbation 6) It is not possible to judge | Up to 3 years |
Not provided
Not provided
Inclusion criteria:
Patients with cervical dystonia
Exclusion criteria:
The patients who participated in this surveillance in the past
Not provided
Not provided
Not provided
Not provided
Patients with cervical dystonia
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Akira Endo | Drug Fostering and Evolution Coordination Department, Eisai Co., Ltd. | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Osaka | Japan | |||||
Not provided
Not provided
Not provided
Not provided
| Tokyo |
| Japan |
| ID | Term |
|---|---|
| D014103 | Torticollis |
| ID | Term |
|---|---|
| D004421 | Dystonia |
| D020820 | Dyskinesias |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided